Sun Pharmaceutical Industries Limited vs Syschem (India) Ltd

A side-by-side comparison of Sun Pharmaceutical Industries Limited (SUNPHARMA) and Syschem (India) Ltd (SYSCHEM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Sun Pharmaceutical Industries Limited leads SUNPHARMA vs SYSCHEM on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth02
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

36.46
P/E ratio
14.05
5.35
P/B ratio
1.15
0.86%
Dividend yield
0.00%
₹47.80
EPS
₹2.50

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

13.74%
Return on equity
8.93%
17.46%
Return on capital
13.88%
30.33%
EBITDA margin
3.22%
19.69%
Net margin
1.67%

Growth

SYSCHEM takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
79.07%
10.57%
Profit CAGR (3Y)
29.78%

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.19L Cr
Market cap
₹188 Cr
₹58,462 Cr
Revenue
₹655 Cr
₹11,509 Cr
Net profit
₹11 Cr
0.06
Debt / equity
0.00
Sun Pharmaceutical Industries Limited
  • + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
  • − ["Stock is trading at 5.00 times its book value"]
Syschem (India) Ltd
  • + ["Company is almost debt free.", "Company has delivered good sales growth of 57.3% CAGR over last 5 years"]
  • − ["Company has a low return on equity of 5.4% over last 3 years."]
Sun Pharmaceutical Industries Limited full analysis Syschem (India) Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.